Perrigo : PRGO

All Perrigo Articles

63 Articles

Jon C. Ogg | Feb 22, 2016 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Deere, Expedia, HP Enterprise, JPMorgan, Phillips 66 and Many More

The top analyst upgrades, downgrades and initiations seen on Monday, February 22, include AbbVie, Deere, Expedia, Hewlett Packard Enterprise, JPMorgan…

Paul Ausick | Feb 18, 2016 at 4:04 PM EST

The 52-Week Low Club for Thursday

February 18, 2016: Here are four stocks trading with heavy volume among 48 equities making new 52-week lows today. Arris…

Jon C. Ogg | Jan 21, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: GE, 3M, Shopify, SunPower, Zafgen, CIT, Ericsson, Honeywell and Many More

Thursday's top analyst calls include General Electric, 3M, Shopify, SunPower, Zafgen, CIT, Ericsson, Honeywell.

Lee Jackson | Dec 22, 2015 at 10:05 AM EST

Jefferies Has 3 Top Blue Chip Value Stocks to Buy Now

With the potential for a year-end rally looking better after Monday's market action, many investors are turning their attention to…

Jon C. Ogg | Dec 10, 2015 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Apollo, Avago, CyberArk, First Solar, JC Penney, KKR, Lululemon, MobileEye, Perrigo, Tesoro and More

Thursday's top analyst upgrades, downgrades and initiations include Apollo Global, Avago Technologies, CyberArk Software, First Solar, JC Penney, KKR, Lululemon…

Jon C. Ogg | Nov 18, 2015 at 8:40 AM EST

Top Analyst Upgrades and Downgrades: Apple, Bluebird, Exxon Mobil, Kinder Morgan, Kinross Gold, Lending Club, Perrigo and Many More

Wednesday's top analyst upgrades, downgrades and initiations include Apple, Bluebird, Exxon Mobil, Kinder Morgan, Kinross Gold, Lending Club and Perrigo.

Chris Lange | Nov 16, 2015 at 1:05 PM EST

What Perrigo and Teva Can Learn From Mylan’s Share Repurchase

Mylan announced Monday that it would be conducting a share repurchase for up to $1 billion, in a much faster…

Chris Lange | Nov 14, 2015 at 9:20 AM EST

7 BioHealth Movers That Cannot Be Ignored

The biotech companies 24/7 Wall St. has picked stood out from the rest with incredible gains or losses over the…

Lee Jackson | Oct 8, 2015 at 10:15 AM EDT

Hot Political Rhetoric Hammers Specialty Pharmaceuticals: 3 to Buy Now

We scanned the Merrill Lynch stock coverage universe for specialty pharmaceutical stocks rated Buy and found three top companies that…

Chris Lange | Aug 25, 2015 at 1:55 PM EDT

Mylan Fires Back at Perrigo

Mylan announced Tuesday, in conjunction with the Irish Takeover Panel, that Perrigo had made misleading statements to shareholders.

Lee Jackson | Aug 20, 2015 at 8:20 AM EDT

Big Catalysts Coming Within a Week for 2 Specialty Pharmaceutical Stocks

ThinkstockWith biotech and specialty pharmaceutical stocks, catalysts and binary events can drive the stocks much higher, or in some cases…

Trey Thoelcke | Jul 15, 2015 at 7:20 AM EDT

Why Teva Pharmaceutical Bid for Mylan May Go Hostile

Teva could be about to enter the largest generic market by prescription in the world, which may tip the scales…

Jon C. Ogg | Jun 23, 2015 at 8:35 AM EDT

Top Analyst Upgrades and Downgrades: Newmont, Vodafone, Yelp, Western Digital, American Airlines, AT&T and More

Tuesday's top analyst upgrades, downgrades and initiations include Newmont Mining, Vodafone, Yelp, Western Digital, American Airlines and AT&T.

Jon C. Ogg | Jun 8, 2015 at 4:48 PM EDT

Is the Teva and Mylan Merger Fight Going to Turn Away Shareholders?

ThinkstockTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) is trying to transform itself by making its generics business even larger if it…

Lee Jackson | Jun 1, 2015 at 8:20 AM EDT

3 Specialty Pharma Stocks That Could Be Acquired in 2015

If there ever was a perfect storm for large pharmaceutical and big-cap biotech companies to make acquisitions to enhance growth…

1 2 3 4 5

Perrigo : PRGO

All Perrigo Articles

Top Analyst Upgrades and Downgrades: AbbVie, Deere, Expedia, HP Enterprise, JPMorgan, Phillips 66 and Many More

The 52-Week Low Club for Thursday

Top Analyst Upgrades and Downgrades: GE, 3M, Shopify, SunPower, Zafgen, CIT, Ericsson, Honeywell and Many More

Jefferies Has 3 Top Blue Chip Value Stocks to Buy Now

Top Analyst Upgrades and Downgrades: Apollo, Avago, CyberArk, First Solar, JC Penney, KKR, Lululemon, MobileEye, Perrigo, Tesoro and More

Top Analyst Upgrades and Downgrades: Apple, Bluebird, Exxon Mobil, Kinder Morgan, Kinross Gold, Lending Club, Perrigo and Many More

What Perrigo and Teva Can Learn From Mylan’s Share Repurchase

7 BioHealth Movers That Cannot Be Ignored

Hot Political Rhetoric Hammers Specialty Pharmaceuticals: 3 to Buy Now

Mylan Fires Back at Perrigo

Big Catalysts Coming Within a Week for 2 Specialty Pharmaceutical Stocks

Why Teva Pharmaceutical Bid for Mylan May Go Hostile

Top Analyst Upgrades and Downgrades: Newmont, Vodafone, Yelp, Western Digital, American Airlines, AT&T and More

Is the Teva and Mylan Merger Fight Going to Turn Away Shareholders?

3 Specialty Pharma Stocks That Could Be Acquired in 2015

XRP Price Prediction: 3 AI Models Predict Where XRP Will Trade by December 2026

QDVO’s 32% Return Masks a Hidden Risk for Income Investors

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

XRP Price Prediction: 3 AI Models Predict Where XRP Will Trade by December 2026

QDVO’s 32% Return Masks a Hidden Risk for Income Investors

Perrigo : PRGO

All Perrigo Articles

Top Analyst Upgrades and Downgrades: AbbVie, Deere, Expedia, HP Enterprise, JPMorgan, Phillips 66 and Many More

The 52-Week Low Club for Thursday

Top Analyst Upgrades and Downgrades: GE, 3M, Shopify, SunPower, Zafgen, CIT, Ericsson, Honeywell and Many More

Jefferies Has 3 Top Blue Chip Value Stocks to Buy Now

Top Analyst Upgrades and Downgrades: Apollo, Avago, CyberArk, First Solar, JC Penney, KKR, Lululemon, MobileEye, Perrigo, Tesoro and More

Top Analyst Upgrades and Downgrades: Apple, Bluebird, Exxon Mobil, Kinder Morgan, Kinross Gold, Lending Club, Perrigo and Many More

What Perrigo and Teva Can Learn From Mylan’s Share Repurchase

7 BioHealth Movers That Cannot Be Ignored

Hot Political Rhetoric Hammers Specialty Pharmaceuticals: 3 to Buy Now

Mylan Fires Back at Perrigo

Big Catalysts Coming Within a Week for 2 Specialty Pharmaceutical Stocks

Why Teva Pharmaceutical Bid for Mylan May Go Hostile

Top Analyst Upgrades and Downgrades: Newmont, Vodafone, Yelp, Western Digital, American Airlines, AT&T and More

Is the Teva and Mylan Merger Fight Going to Turn Away Shareholders?

3 Specialty Pharma Stocks That Could Be Acquired in 2015

XRP Price Prediction: 3 AI Models Predict Where XRP Will Trade by December 2026

QDVO’s 32% Return Masks a Hidden Risk for Income Investors

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

Featured Reads

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk